Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 40,15
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 40,61
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 38,63
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 38,62
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 44,15
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 66,97
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: moluna, Greven, Alemania
EUR 34,25
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: preigu, Osnabrück, Alemania
EUR 36,25
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Orodispersible Tablets Of Rizatriptan Benzoate | Formulation And Evalution | Swati Siddheshwar Londhe (u. a.) | Taschenbuch | 76 S. | Englisch | 2020 | LAP LAMBERT Academic Publishing | EAN 9786202553124 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Idioma: Inglés
Publicado por LAP Lambert Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
EUR 42,50
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Idioma: Inglés
Publicado por LAP Lambert Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
EUR 40,09
Cantidad disponible: Más de 20 disponibles
Añadir al carritoPAP. Condición: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Mai 2020, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 39,90
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In the present investigate is an attempt towards developing a formulation of Anti-migraine drug. Innovations in the area of Oral Dispersible Tablets are aimed at both increasing the performance of the dosage form by decreasing the disintegration time and increasing the patient compliance by masking the objectionable taste of the ingredient by direct compression technique. It containing Rizatriptan Benzoate as model drug used for the treatment of migraine disease. Formulation were prepared by using different Super disintegrate and suggested nine formulation F01-F09 & prepared Oral Dispersible Tablets F01-F09 by direct compression techniques containing Croscarmellose sodium and Crospovidone as Super disintegrant in different concentration (10.5,13.0 and 15.5mg). Optimized F08 formulation containing concentration of Crospovidone 10.5mg, Pregelatinized Starch 20mg, Aspartame 5mg as sweetener and Peppermint 1mg as flavor, Mannitol 94.77mg, Microcrystalline cellulose Avicel pH 101 37.20mg &Avicel pH 102 5mg, and Mag Stearate 12mg were used and further evaluated. 76 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: Majestic Books, Hounslow, Reino Unido
EUR 65,29
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 66,89
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Mai 2020, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 39,90
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In the present investigate is an attempt towards developing a formulation of Anti-migraine drug. Innovations in the area of Oral Dispersible Tablets are aimed at both increasing the performance of the dosage form by decreasing the disintegration time and increasing the patient compliance by masking the objectionable taste of the ingredient by direct compression technique. It containing Rizatriptan Benzoate as model drug used for the treatment of migraine disease. Formulation were prepared by using different Super disintegrate and suggested nine formulation F01-F09 & prepared Oral Dispersible Tablets F01-F09 by direct compression techniques containing Croscarmellose sodium and Crospovidone as Super disintegrant in different concentration (10.5,13.0 and 15.5mg). Optimized F08 formulation containing concentration of Crospovidone 10.5mg, Pregelatinized Starch 20mg, Aspartame 5mg as sweetener and Peppermint 1mg as flavor, Mannitol 94.77mg, Microcrystalline cellulose Avicel pH 101 37.20mg &Avicel pH 102 5mg, and Mag Stearate 12mg were used and further evaluated.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 76 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2020
ISBN 10: 620255312X ISBN 13: 9786202553124
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 40,89
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In the present investigate is an attempt towards developing a formulation of Anti-migraine drug. Innovations in the area of Oral Dispersible Tablets are aimed at both increasing the performance of the dosage form by decreasing the disintegration time and increasing the patient compliance by masking the objectionable taste of the ingredient by direct compression technique. It containing Rizatriptan Benzoate as model drug used for the treatment of migraine disease. Formulation were prepared by using different Super disintegrate and suggested nine formulation F01-F09 & prepared Oral Dispersible Tablets F01-F09 by direct compression techniques containing Croscarmellose sodium and Crospovidone as Super disintegrant in different concentration (10.5,13.0 and 15.5mg). Optimized F08 formulation containing concentration of Crospovidone 10.5mg, Pregelatinized Starch 20mg, Aspartame 5mg as sweetener and Peppermint 1mg as flavor, Mannitol 94.77mg, Microcrystalline cellulose Avicel pH 101 37.20mg &Avicel pH 102 5mg, and Mag Stearate 12mg were used and further evaluated.